FDA Approved: BIMATOPROST — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for bimatoprost filed by Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

SUPPL AP for BIMATOPROST (BIMATOPROST)